eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Catscratch Disease

Author: Allan D Friedman, MD, MPH, Chairman, Division of General Pediatrics, Dept of Pediatrics, Professor of Pediatrics, Virginia Commonwealth University, VCUH Health System
Contributor Information and Disclosures

Updated: Apr 28, 2009

Introduction

Background

Catscratch disease (CSD) was first described in the mid 20th century; the first individual with catscratch disease was a 10-year-old boy in Paris, France. The signs and symptoms of catscratch disease widely vary; regional adenopathy is the most common symptom.1 Many organ systems can be affected. A skin papule at the sight of inoculation often occurs prior to the development of adenopathy. Catscratch disease is the most common cause of chronic adenopathy in children. Typically, the incubation period is 3-10 days.

Kittens are more likely to transmit the infection than older cats. Owners of kittens younger than 12 months are 15 times more likely to develop catscratch disease than owners of adult cats. Fleas are also most likely vectors for disease. More than 90% of patients infected with catscratch disease have a recent history of contact with a cat, usually a kitten. Risk factors for catscratch disease include ownership of a kitten younger than 12 months, a scratch or bite from a kitten, and ownership of at least one cat with fleas. catscratch disease secondary to a dog bite has also been reported.2

Papulopustular lesions of a primary inoculation s...

Papulopustular lesions of a primary inoculation site on the hand of a 16-year-old patient. These lesions had been present for approximately 3 weeks. A catscratch antigen skin test was positive with 15-mm induration. No treatment was administered, and her condition spontaneously resolved in 2.5 months. Courtesy of Andrew Margileth, MD.

Papulopustular lesions of a primary inoculation s...

Papulopustular lesions of a primary inoculation site on the hand of a 16-year-old patient. These lesions had been present for approximately 3 weeks. A catscratch antigen skin test was positive with 15-mm induration. No treatment was administered, and her condition spontaneously resolved in 2.5 months. Courtesy of Andrew Margileth, MD.



A crusted primary inoculation papule on the neck ...

A crusted primary inoculation papule on the neck of a 4-year-old child. Note the adjacent lymphadenitis. This patient had contact with cats and had multiple scratches. Courtesy of Andrew Margileth, MD.

A crusted primary inoculation papule on the neck ...

A crusted primary inoculation papule on the neck of a 4-year-old child. Note the adjacent lymphadenitis. This patient had contact with cats and had multiple scratches. Courtesy of Andrew Margileth, MD.


This 13-year-old girl developed fatigue and malai...

This 13-year-old girl developed fatigue and malaise after being licked and scratched by a cat. The typical conjunctival granuloma was accompanied by a parotid mass and intraparotid adenitis. No treatment was administered, and all her signs and symptoms resolved in 3 months. Courtesy of Andrew Margileth, MD.

This 13-year-old girl developed fatigue and malai...

This 13-year-old girl developed fatigue and malaise after being licked and scratched by a cat. The typical conjunctival granuloma was accompanied by a parotid mass and intraparotid adenitis. No treatment was administered, and all her signs and symptoms resolved in 3 months. Courtesy of Andrew Margileth, MD.


This 9-year-old boy developed catscratch disease ...

This 9-year-old boy developed catscratch disease (CSD) encephalitis and a papular pruritic dermatitis after sustaining cat scratches and developing regional lymphadenitis. He was in a coma for 4 days but experienced a complete and rapid recovery within 3 weeks. Biopsy of the skin rash revealed nonspecific changes. The CSD antigen skin test result was positive. Courtesy of Andrew Margileth, MD.

This 9-year-old boy developed catscratch disease ...

This 9-year-old boy developed catscratch disease (CSD) encephalitis and a papular pruritic dermatitis after sustaining cat scratches and developing regional lymphadenitis. He was in a coma for 4 days but experienced a complete and rapid recovery within 3 weeks. Biopsy of the skin rash revealed nonspecific changes. The CSD antigen skin test result was positive. Courtesy of Andrew Margileth, MD.


This 2.5-year-old boy was recovering from catscra...

This 2.5-year-old boy was recovering from catscratch disease acquired 10 months before when he developed this neck abscess over a period of 3 weeks. Biopsy revealed caseating granulomas; acid-fast bacillus and Warthin-Starry stain results were negative. Courtesy of Andrew Margileth, MD.

This 2.5-year-old boy was recovering from catscra...

This 2.5-year-old boy was recovering from catscratch disease acquired 10 months before when he developed this neck abscess over a period of 3 weeks. Biopsy revealed caseating granulomas; acid-fast bacillus and Warthin-Starry stain results were negative. Courtesy of Andrew Margileth, MD.


Pathophysiology

Most cases of catscratch disease are caused by Bartonella henselae. The bacteria, formerly classified as Rochalimaea henselae, are slow-growing, fastidious, pleomorphic, gram-negative organisms. In addition to lymphatics, infection can affect the CNS, eyes, liver, spleen, bone, and lungs. Erythema nodosum and thrombocytopenia purpura have also been reported. The primary inoculation site and involved lymph nodes show a central area of avascular necrosis surrounded by lymphocytes. Histiocytes and giant cells are often present.

Frequency

United States

The incidence rate is believed to be at least 9.3 per 100,000 population or more than 22,000 cases of catscratch disease per year. In temperate climates, catscratch disease predominantly occurs in autumn and winter; in the tropics, seasonal changes in frequency of the disease are not observed. Hospitalization rates vary from 0.6-0.86 per 100,000 children. The median hospitalization charge for catscratch disease has been estimated to be $46,140, and annual expenses are estimated to be about $3.5 million.

International

Distribution of catscratch disease is worldwide. Incidence rates reflect cat populations in each country.

Mortality/Morbidity

Catscratch disease is usually self-limited and benign. Patients with prolonged courses of the disease usually fully recover. Reinfection is infrequent. Death caused by catscratch disease in patients who are immunocompetent is extremely rare.

Sex

CSD is observed more frequently in males than females. This probably reflects an increased risk of exposure to infected kittens and an increased risk of bites and scratches from the infected animal.

Age

Although some studies suggest that approximately 60% of cases of catscratch disease occur in patients younger than 20 years, older literature suggests that incidence in this age group may have been as high as 80%.

Clinical

History

  • A history of contact with a cat, usually a kitten, in the previous 1-2 weeks is common in individuals with catscratch disease (CSD). The patient often remembers being bitten or scratched by the cat.
  • The classic history of an individual with catscratch disease is a local rash followed by adenopathy.
    • The rash is present in more than 90% of patients infected with the disease and usually lasts until adenopathy occurs, which is a period of 1-4 weeks.
    • The rash consists of one or more red papules that are 0.5 cm or less in diameter and appear at the site of inoculation, which is often a cat scratch or bite.
  • Lymphadenitis usually persists 4-6 weeks but can last one year or longer.
    • Axillary nodes are most frequently affected, followed by cervical, submandibular, and preauricular nodes.
    • Single node involvement occurs in more than one half of individuals with catscratch disease. The typical node size is 1-5 cm in diameter.
  • Fever of unknown origin may be present in one third of patients with catscratch disease.
  • Fatigue is also present in one third of patients with catscratch disease.
  • Parinaud oculoglandular syndrome occurs in 2-3% of patients with catscratch disease.
  • CNS findings are present in 5% of patients with catscratch disease and include headaches, mental status changes, seizures, myelitis, transient peripheral neuropathy, and retinitis.

Physical

  • Skin lesions typically evolve from vesicular to erythematous papular lesions. Papules may have an overlapping crust. Soon after the onset of adenopathy, skin lesions may disappear.
  • Affected lymph nodes are tender with red, warm, indurated skin over the nodes. Many of the lesions may suppurate. Occasionally, a sinus track may form. Nodes that drain may heal with scarring. Occasionally, node enlargement lasts 4-6 weeks.
  • Fever may be present in one third of patients with catscratch disease and may last 1-2 weeks. In a series of prolonged fever without a source, catscratch disease was one of the most common diagnoses.3
  • Fatigue is also present in one third of cases and may persist for weeks to months.
  • Parinaud oculoglandular syndrome, which is characterized by unilateral conjunctivitis and regional lymphadenitis, occurs in 2-3% of patients with catscratch disease.
    • In these patients, the site of inoculation is usually the eyelid or conjunctiva secondary to a lick, scratch, or bite. Subsequent rubbing of the eye often leads to spreading.
    • After a few weeks, the patient develops nonpurulent conjunctivitis, an ocular granuloma, or both. Preauricular adenopathy also develops.
    • Physical findings involving the eye resolve in a few months without residual damage.
  • CNS findings occur in 5% of patients with catscratch disease and include encephalitis, seizures, myelitis, peripheral neuropathy, and retinitis.
    • Headaches and mental status changes occur 2-3 weeks after onset of the disease and are frequently the initial findings of the encephalopathy.4
    • Patients with encephalitis may have seizures.
    • Myelitis presents with extremity weakness, abnormal reflexes, sensory loss, and sphincter dysfunction.
    • Bell palsy has been described in patients with catscratch disease.
    • Acute onset, self-resolving, recurrent expressive aphasia has been reported.
    • Other CNS findings include transient peripheral neuropathy and optic neuritis and neuroretinitis presenting as unilateral blindness.
    • Recovery from CNS manifestations may be slow; some individuals with catscratch disease require one year or longer to recover from CNS manifestations.
  • An individual with catscratch disease may present with a fever of unknown origin. Adenopathy may not be present. Abdominal pain may be the initial finding, along with fever, for hepatosplenic catscratch disease.
  • Characterized by painful, tender, subcutaneous nodules on the skin, erythema nodosum may present 1-6 weeks after onset of adenopathy in less than 1% of patients with catscratch disease. These nodules resolve without sequelae.
  • A transitory rash may occur early in the course of the disease. Most commonly, the rash is an evanescent maculopapular rash.
    • Thrombocytopenia purpura is quite rare and is usually transient.
    • Osteomyelitis, manifesting by fever and bone pain, has been reported. 
    • A few patients with catscratch disease have been described with osteolytic lesions but not true osteomyelitis. These patients do not have a fever or leukocytosis.
    • Sites of node involvement are remote from the site of inoculation of B henselae, suggesting hematogenous spread. Biopsy of these lesions demonstrates granulomatous reactions.
  • Endocarditis with immune-mediated manifestations has been described. Immunocompromised patients may present with insidious back pain due to vertebral osteomyelitis. Other findings in immunocompromised patients include cysts in the liver and spleen, painful tumors, angiomatosis, and peliosis.
  • Back pain as the presenting symptom has been reported. In one case report, CT scanning revealed a soft tissue mass dorsal to the processi transversa L1-2, and MRI revealed a contrast-enhancing paraspinal mass with infiltration of the erector spinae consistent with inflamation.5  B henselae immunoglobulin (Ig)M antibody findings were positive. The patient spontaneously recovered after about one month.

Causes

  • Catscratch disease appears to be caused by B henselae.
  • Afipia felis, at one time thought to be a major etiologic agent of catscratch disease, has now been excluded as a significant cause.
  • Disseminated illness occurs in less than 1% of patients with catscratch disease. It is manifested by persistent spiking fever, hepatosplenomegaly, and abdominal pain associated with diffuse granulomatous liver and spleen.

More on Catscratch Disease

Overview: Catscratch Disease
Differential Diagnoses & Workup: Catscratch Disease
Treatment & Medication: Catscratch Disease
Follow-up: Catscratch Disease
Multimedia: Catscratch Disease
References

References

  1. Da Silva K, Chussid S. Cat scratch disease: clinical considerations for the pediatric dentist. Pediatr Dent. Jan-Feb 2009;31(1):58-62. [Medline].

  2. Chen TC, Lin WR, Lu PL, Lin CY, Chen YH. Cat scratch disease from a domestic dog. J Formos Med Assoc. Feb 2007;106(2 Suppl):S65-68. [Medline].

  3. Malatack JJ, Jaffe R. Granulomatous hepatitis in three children due to cat-scratch disease without peripheral adenopathy. An unrecognized cause of fever of unknown origin. Am J Dis Child. Sep 1993;147(9):949-53. [Medline].

  4. Cherinet Y, Tomlinson R. Cat scratch disease presenting as acute encephalopathy. Emerg Med J. Oct 2008;25(10):703-4. [Medline].

  5. ten Hove CH, Gubler FM, Kiezebrink-Lindenhovius HH. Back pain in a child caused by cat scratch disease. Pediatr Infect Dis J. Mar 2009;28(3):258. [Medline].

  6. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. Nov 15 2005;41(10):1373-406. [Medline].

  7. Anderson B, Sims K, Regnery R, et al. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol. Apr 1994;32(4):942-8. [Medline].

  8. Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J. Feb 1997;16(2):163-79. [Medline].

  9. Batts S, Demers DM. Spectrum and treatment of cat-scratch disease. Pediatr Infect Dis J. Dec 2004;23(12):1161-2. [Medline].

  10. Bogue CW, Wise JD, Gray GF, Edwards KM. Antibiotic therapy for cat-scratch disease?. JAMA. Aug 11 1989;262(6):813-6. [Medline].

  11. Dalton MJ, Robinson LE, Cooper J, et al. Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med. Aug 7-21 1995;155(15):1670-6. [Medline].

  12. Delahoussaye PM, Osborne BM. Cat-scratch disease presenting as abdominal visceral granulomas. J Infect Dis. Jan 1990;161(1):71-8. [Medline].

  13. Fox JW, Studley JK, Cohen DM. Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. Pediatrics. Mar 2007;119(3):e760-3. [Medline].

  14. Hajjaji N, Hocqueloux L, Kerdraon R, Bret L. Bone infection in cat-scratch disease: a review of the literature. J Infect. May 2007;54(5):417-21. [Medline].

  15. Hipp SJ, O'Shields A, Fordham LA, et al. Multifocal bone marrow involvement in cat-scratch disease. Pediatr Infect Dis J. May 2005;24(5):472-4. [Medline].

  16. Margileth AM. Dermatologic manifestations and update of cat scratch disease. Pediatr Dermatol. Feb 1988;5(1):1-9. [Medline].

  17. Margileth AM, Wear DJ, English CK. Systemic cat scratch disease: report of 23 patients with prolonged or recurrent severe bacterial infection. J Infect Dis. Mar 1987;155(3):390-402. [Medline].

  18. Peter, G, ed. Cat scratch disease. In: Red Book: Report of the Committee on Infectious Disease. 24th ed. 1997:165-6.

  19. Reynolds MG, Holman RC, Curns AT, et al. Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J. Aug 2005;24(8):700-4. [Medline].

  20. Rolain JM, Chanet V, Laurichesse H, et al. Cat scratch disease with lymphadenitis, vertebral osteomyelitis, and spleen abscesses. Ann N Y Acad Sci. Jun 2003;990:397-403. [Medline].

  21. Spach DH, Koehler JE. Bartonella-associated infections. Infect Dis Clin North Am. Mar 1998;12(1):137-55. [Medline].

  22. Tolan RW Jr, Schibler KR, Galliani CA, Kleiman MB. Unusual systemic, pseudomalignant manifestations of cat-scratch disease in siblings. Pediatr Infect Dis J. Dec 1990;9(12):913-6. [Medline].

  23. Wong MT, Dolan MJ, Lattuada CP Jr, et al. Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis. Aug 1995;21(2):352-60. [Medline].

Further Reading

Keywords

catscratch disease, CSD, cat scratch disease, cat-scratch disease, cat bite, benign inoculation lymphoreticulosis, benign inoculation reticulosis, cat-scratch fever, regional granulomatous lymphadenitis, regional adenopathy, , , erythema nodosum, thrombocytopenia purpura, Parinaud oculoglandular syndrome, myelitis, transient peripheral neuropathy, retinitis, encephalitis, Bell palsy, hepatosplenic catscratch disease, endocarditis, rash, skin rash, abdominal pain, kitten bite, kitten scratch, treatment, diagnosis, back pain

Contributor Information and Disclosures

Author

Allan D Friedman, MD, MPH, Chairman, Division of General Pediatrics, Dept of Pediatrics, Professor of Pediatrics, Virginia Commonwealth University, VCUH Health System
Allan D Friedman, MD, MPH is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Medical Editor

Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine
Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Joseph Domachowske, MD, Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University
Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; sanofi pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.